Mission Typeone is a dynamic and flexible company whose main activities are the production and marketing of type I collagen of animal origin and the development/prototyping of novel collagen-based products for Advanced Therapies, with a special focus on Tissue Engineering applications.

In particular, the company works on the development of implantable scaffolds for nerve, bone, skin, tendon and ligament regeneration, as well as on the manufacture of substrates for Tissue Culture. The corporate business model involves the development of products up to Phase II clinical trials, and then the transfer of licenses on intellectual property and brands to Big Pharma companies, with agreements for Phase III trials, Milestones and Royalties.